NTHI (NeOnc Technologies Holdings) PS Ratio: (As of Jul. 07, 2026)


NTHI NeOnc Technologies Holdings Inc NTHI
7 GF Score
Price $4.36
! 1 Warning Sign
View Full Analysis

What is NeOnc Technologies Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, NeOnc Technologies Holdings's share price is $4.36. NeOnc Technologies Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Hence, NeOnc Technologies Holdings's PS Ratio for today is .

The historical rank and industry rank for NeOnc Technologies Holdings's PS Ratio or its related term are showing as below:

NTHI' s PS Ratio Range Over the Past 10 Years
Min: 920   Med: 2678.34   Max: 5120
Current: 2180

During the past 5 years, NeOnc Technologies Holdings's highest PS Ratio was 5120.00. The lowest was 920.00. And the median was 2678.34.

NTHI's PS Ratio is ranked worse than
97.63% of 929 companies
in the Biotechnology industry
Industry Median: 9.64 vs NTHI: 2180.00

NeOnc Technologies Holdings's Revenue per Sharefor the three months ended in Mar. 2026 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

During the past 12 months, the average Revenue per Share Growth Rate of NeOnc Technologies Holdings was -100.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 26.00% per year.

During the past 5 years, NeOnc Technologies Holdings's highest 3-Year average Revenue per Share Growth Rate was 26.00% per year. The lowest was 26.00% per year. And the median was 26.00% per year.

Back to Basics: PS Ratio


NeOnc Technologies Holdings  (NAS:NTHI) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


NeOnc Technologies Holdings PS Ratio Related Terms


NeOnc Technologies Holdings PS Ratio Historical Data

* Premium members only.

The historical data trend for NeOnc Technologies Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeOnc Technologies Holdings PS Ratio Chart

NeOnc Technologies Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
0.00 0.00 0.00 0.00 4,135.00

NeOnc Technologies Holdings Quarterly Data
Dec21 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,340.00 1,190.00 3,026.67 4,135.00 0.00

NTHI vs GUTS, PEPG, ENGN: PS Ratio Comparison

For the Biotechnology subindustry, NeOnc Technologies Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeOnc Technologies Holdings PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NeOnc Technologies Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where NeOnc Technologies Holdings's PS Ratio falls into.


NTHI
7GF Score
NeOnc Technologies Holdings Inc NTHI
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeOnc Technologies Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

NeOnc Technologies Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=4.36/0
=

NeOnc Technologies Holdings's Share Price of today is $4.36.
NeOnc Technologies Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


NeOnc Technologies Holdings Business Description

Address 23975 Park Sorrento, Suite 205, Calabasas, CA, USA, 91302
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
7GF Score

Get the complete analysis for NTHI

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.36
Price